Search Results for citation:"90 FR 8173"

Found 2 results
Skip to main content

Search Results: citation:"90 FR 8173"

  • Type:Rule
    Citation:90 FR 8173
    Reading Time:less than a minute

    The Consumer Financial Protection Bureau issued a correction to a previously published rule concerning the use of medical information by creditors and consumer reporting agencies. The correction changes the date mentioned in the DATES section from "March 17, 2024" to "March 17, 2025". This change was necessary to accurately reflect the intended implementation timeline. The correction was made on January 14, 2025.

    Simple Explanation

    The rule about how banks and companies use people's medical information had the start date wrong, so they changed it from 2024 to 2025. This means everyone affected has an extra year to get ready.

  • Type:Rule
    Citation:90 FR 8173
    Reading Time:about 4 minutes

    The Food and Drug Administration (FDA), under the Department of Health and Human Services, has delayed the effective date of a rule regarding nonprescription drug products with an additional condition for nonprescription use (ACNU). Originally set to take effect on January 27, 2025, the rule is postponed to March 21, 2025, due to a memorandum from the President calling for a "Regulatory Freeze Pending Review." This delay is intended to allow further examination of the rule and its implications, ensuring it aligns with legal and policy considerations. The rule outlines requirements for nonprescription drugs involving applications, labeling, and postmarketing reporting, differentiating them from prescription drugs based on these additional conditions.

    Simple Explanation

    The government wants to wait a little longer before a new rule about some medicines you can buy without a doctor's note takes effect. They think it's important to take more time to make sure the rule is really good and works like they want it to.